Founded in 2001, Delphi Genetics S.A., located in Gosselies Belgium, focuses on developing new, much more effective products and technologies for gene cloning and protein expression in bacteria.
The products and services developed by Delphi Genetics are based on unique technologies using bacterial poison-antidote genes. Our patented Staby® technology improves DNA cloning reliability and efficiency, allowing successful cloning of genes and expression of recombinant proteins that had been impossible to clone or express with standard methods.
The Staby® technology allows producing proteins and DNA without the use of antibiotics. This is of special importance for large scale protein or DNA productions in the Biopharmaceutical Industry. Our patented stabilization technology dramatically improves the overall production yield and reproducibility. Our technology enables you to implement a completely “antibiotic-free“ production platform thus complying with the latest FDA and EMEA standards.
Through its Staby Operating System, an innovative set of bacterial strains and vectors integrating the Staby technology, Delphi Genetics offers a comprehensive range of molecular tools for DNA cloning and Protein expression.
Through its “Never Clone Alone“ Platform, Delphi Genetics is a dedicated service provider for custom services in Molecular cloning and Gene expression. We also offers research and development services for the biopharmaceutical industry.